Publication Date:
2015-11-01
Description:
Article Using molecular markers is a useful way to predict the prognosis of cancer patients. Here, Wei et al. describe a five gene methylation signature that can predict the prognosis of renal clear cell cancer and validate its use in multiple patient cohorts. Nature Communications doi: 10.1038/ncomms9699 Authors: Jin-Huan Wei, Ahmed Haddad, Kai-Jie Wu, Hong-Wei Zhao, Payal Kapur, Zhi-Ling Zhang, Liang-Yun Zhao, Zhen-Hua Chen, Yun-Yun Zhou, Jian-Cheng Zhou, Bin Wang, Yan-Hong Yu, Mu-Yan Cai, Dan Xie, Bing Liao, Cai-Xia Li, Pei-Xing Li, Zong-Ren Wang, Fang-Jian Zhou, Lei Shi, Qing-Zuo Liu, Zhen-Li Gao, Da-Lin He, Wei Chen, Jer-Tsong Hsieh, Quan-Zhen Li, Vitaly Margulis, Jun-Hang Luo
Electronic ISSN:
2041-1723
Topics:
Biology
,
Chemistry and Pharmacology
,
Natural Sciences in General
,
Physics
Permalink